Troponin in critical care patients and outcomes

Elizabeth M Cole1, Annemarie B Docherty2

  • 1Department of Anaesthesia, NHS Lothian, Edinburgh, UK.

Insights

Critically ill patients with cardiovascular disease often experience unrecognized myocardial infarction, leading to higher mortality. Early identification and management of oxygen supply-demand imbalance can improve outcomes.

Area of Science:

  • Critical Care Medicine
  • Cardiology
  • Biomarkers

Background:

  • Myocardial infarction (MI) is a frequent complication in critically unwell patients, particularly those with pre-existing cardiovascular disease.
  • MI in this population is linked to significantly increased overall mortality.
  • A substantial number of intensive care unit (ICU) patients with acute MI remain undiagnosed.

Purpose of the Study:

  • To explore current guidelines for diagnosing myocardial infarction in critically ill patients.
  • To review research on the utility of troponin as a diagnostic and prognostic marker.
  • To highlight the potential for improved patient outcomes through risk identification and care modification.

Main Methods:

  • Review of existing clinical guidelines for MI diagnosis.
  • Analysis of research studies investigating troponin's role in diagnosis and prognosis.
  • Discussion of the pathophysiology of MI in the critically unwell, focusing on oxygen supply-demand imbalance.

Main Results:

  • The majority of acute myocardial infarctions in the ICU setting are currently unrecognized.
  • Oxygen supply-demand imbalance is the predominant underlying cause of MI in this cohort.
  • Troponin assays are valuable diagnostic and prognostic tools.

Conclusions:

  • Improved recognition of myocardial infarction in critically ill patients is crucial.
  • Addressing oxygen supply-demand imbalance offers a potential strategy to reduce mortality.
  • Utilizing troponin effectively can aid in both diagnosis and prognosis, leading to better patient management.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
689
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
142
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
434
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
159
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
652
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
205